Does Medicare cover Wegovy?
Short answer: Yes — through three distinct doors, and which one is yours matters for cost. Weight loss under the Bridge's BMI tiers: flat $50/month. Established heart disease: Part D under Wegovy's cardiovascular indication. MASH (fatty liver with fibrosis): Part D under its MASH indication. The Part D paths count toward your out-of-pocket cap and accept Extra Help; the Bridge doesn't.
Program facts last verified against CMS: July 21, 2026
Which door is yours
The Bridge door: BMI 35+, or 30+/27+ with qualifying conditions, no routing diagnoses — $50 flat, nationwide, through the program's central processor. The cardiovascular door: with documented heart disease plus overweight, Wegovy's FDA-approved risk-reduction indication supports standard Part D coverage under your plan's terms. The MASH door: noncirrhotic MASH with fibrosis supports Part D coverage under that indication.
Some people genuinely fit more than one door — a prior heart attack, for instance, is both a Bridge Tier 3 qualifier and the basis of the cardiovascular indication. Which path your prescriber uses affects your costs: Part D payments accumulate toward the ~$2,100 cap and accept Extra Help; the Bridge's $50 does neither. If you have Extra Help or heavy drug spending, ask your prescriber about the Part D route specifically.
Take the 2-minute eligibility check →
Common questions
Is Wegovy covered for simple weight loss?
Yes — that's exactly what the Bridge program exists for, at $50/month through December 2027, if you meet the BMI tiers.
Which Wegovy path is cheapest?
It depends: the Bridge is a predictable $50, but the Part D paths (heart disease or MASH) can be cheaper across a year if you have Extra Help or hit the out-of-pocket cap from other medications.
Do all Part D plans cover Wegovy for heart disease?
Coverage under the cardiovascular indication is established, but formulary tiers and prior-authorization terms vary by plan — worth comparing during Open Enrollment if this is your path.
Related
Program-fact sources: CMS — Medicare GLP-1 Bridge · KFF